Abstract: A number of drugs have been used to treat asphyxia in new-born calves and the aim of the current study was to investigate the effect of commonly-used stimulant drugs on ventilation, arterial blood gas and acid base variables. A group (n = 18) of new-born (3-15 h old) calves were treated in a randomised sequence with doxapram (40 mg, IV), lobeline (5 mg, IV) or prethcamide (5 mL, consisting of 375 mg crotethamide and 375 mg cropropamide, buccally). Blood and spirometric measurements, using an ultrasonic spirometer, were collected prior to and 1, 5, 15, 30, 60, 90 min after administration of each drug. Doxapram caused a significant increase in the respiratory rate, peak inspiratory and expiratory flow and minute volume (Vmin) during the 90-min post-treatment study period, although maximum values occurred 1 min after treatment. The Vmin increased from 13.8 ± 5.0 L to 28.5 ± 12.3 L. Prethcamide, but not lobeline, also caused significant increases in inspiratory and expiratory volumes. The effects of doxapram on ventilation were accompanied by an increase in arterial partial pressure of oxygen (PaO2) (77.7 ± 18.8 mm Hg to 93.2 ± 23.7 mm Hg), a decrease in arterial partial pressure of carbon dioxide (PaCO2) (42.6 ± 4.9 mm Hg to 33.1 ± 6.6 mm Hg), a significant increase in pH and a decrease in bicarbonate concentration and base excess 1 min after treatment. Prethcamide caused a gradual increase in PaO2 and decrease in PaCO2 over 90 min, whereas lobeline had no measurable effect on the investigated variables. Of the three treatments, only doxapram had a distinct stimulatory effect on respiration in healthy neonatal calves and may therefore be useful in the treatment of calf asphyxia. 18.8 mmHg to 93.2 ± 23.7 mmHg), a decrease in arterial partial pressure of carbon dioxide 25 (P a CO 2 ) (42.6 ± 4.9 mmHg to 33.1 ± 6.6 mmHg), a significant increase in pH and a significant 26 decrease in bicarbonate concentration and base excess at 1 min after treatment. Prethcamide 27 caused a gradual increase in P a O 2 and decrease in P a CO 2 over 90 min, whereas lobeline had no 
significant increases in inspiratory and expiratory volumes. The effects of doxapram on 23 ventilation were accompanied by an increase in arterial partial pressure of oxygen (P a O 2 ) (77.7 ± 24 18.8 mmHg to 93.2 ± 23.7 mmHg), a decrease in arterial partial pressure of carbon dioxide 25 (P a CO 2 ) (42.6 ± 4.9 mmHg to 33.1 ± 6.6 mmHg), a significant increase in pH and a significant 26 decrease in bicarbonate concentration and base excess at 1 min after treatment. Prethcamide 27 caused a gradual increase in P a O 2 and decrease in P a CO 2 over 90 min, whereas lobeline had no 28 measurable effect on the investigated variables. Of the three treatments, only doxapram had a 29 distinct stimulatory effect on respiration in healthy neonatal calves and may therefore be useful to 30 treat asphyxia in calves.
Introduction

35
The high rate of perinatal calf mortality following dystocia is a significant problem in Doxapram affects chemoreceptors of the carotid artery and aorta. This is mediated by 55 potassium channels, which belong to the TASK K 2P channels. However, doxapram also has a 56 direct effect on the respiratory centre, but the mechanism of action is unknown (Yost, 2006 which was followed by a wash-out period of 2 h before the next drug was given. Another 2 h 106 6 wash-out period followed the 90 min measurement period, and then the third drug was given. The 107 study design ensured that all three respiratory stimulants were administered in a random order to 108 avoid potential confounding effects of the sequence of administration. ) and base excess (BE) were also measured using the blood 118 gas analyser (Rapidlab 248, Siemens). This instrument uses three different sensors for measuring 119 P a O 2 , P a CO 2 and pH, which are corrected for body temperature of the calf. The remainder 120 parameters were calculated by the blood gas analyser.
122
Spirometry
123
Heart and respiratory rates and body temperature were measured immediately before each 124 blood collection, after which spirometric measurements were carried out using an equipped with a rubber collar, with an approximated equipment dead space of 1500 mL, as 134 determined by water displacement, was used for the measurements (Fig. 1) . The anterior opening 135 of the mask was adapted to the size of the spirette such that the entire airflow passed through it. 
Statistical analysis
150
The data were checked for normal distribution using the Shapiro-Wilk test and statistical 151 analyses were performed using Stat View 5.0 (SAS Institute). All parameters were normally 152 distributed, so results were given as mean ± standard deviation ( x ± SD). To verify if the results
153
were influenced by the sequence of administered stimulant, one-way ANOVA was used to 
Results
166
Clinical signs indicative of adverse side effects of the respiratory stimulants were not 167 observed in any of the calves during the study period. The anaesthetic mask was well tolerated 168 and no disturbances of the spirometric measurements due to movements of the calves were 169 observed. There were no significant differences in baseline values between treatment groups for 170 any measured variables. The rectal temperature ranged from 38.3 -38.8 °C and the heart rate 171 from 109 -129 beats/min; there were no significant changes over time in the latter variable.
172
Within 1 min of doxapram administration, the RR increased from 69 ± 23 breaths/min to 105 ± 173 33 breaths/min (P < 0.001; Fig. 2a ). Lobeline and prethcamide had no significant effect on RR. Lobeline and prethcamide had no effect on PIF and PEF, whereas doxapram led to an 177 increase in both PIF and PEF (P < 0.001). The highest PIF value of 1.59 ± 0.69 L/s occurred 1 178 9 min after doxapram administration, and the measurements remained significantly higher than the 179 baseline value of 0.79 ± 0.21 L/s for 60 min (Fig. 2b) . Likewise, the PEF increased from the 
Blood gas analysis
203
Over the 90 min recording period, there were significant differences among the three 204 treatments with respect to P a O 2 (Fig. 3a) . Doxapram led to a significant increase in P a O 2 from 205 77.7 ± 18.9 mmHg to a maximum value of 93.2 ± 23.7 mmHg at 1 min. Prethcamide caused a There were significant differences among the three treatments with respect to P a CO 2 (P < 210 0.0001). Doxapram caused a significant decrease in P a CO 2 from a baseline value of 42.6 ± 4.9 211 mmHg to 33.1 ± 6.6 mmHg at 1 min, and the measurements remained decreased throughout the 212 study period (Fig. 3b) . Prethcamide caused a significant gradual decrease in P a CO2 from the 213 baseline value of 42.0 ± 4.9 mmHg to a minimum of 38.5 ± 6.4 mmHg at 30 min (P ≤ 0.05).
214
Lobeline did not affect P a CO 2 .
216
The sO 2 profiles of arterial blood did not differ among treatments. Doxapram caused a 217 transient increase in sO 2 from a baseline value of 91 ± 10 % -95 ± 7 % at 1 min (P < 0.01). hyperventilatory hypocapnia (P a CO 2 < 35 mmHg), which may have resulted in a rise in pH to the 265 alkalotic range. A low P a CO 2 causes a shift in the carbonic-acid-bicarbonate equilibrium toward 266 CO 2 and H 2 O production (Meyfeldt, 2004) , which is associated with decreasing bicarbonate 267 concentration and decreasing BE, consistent with the current study, for at least 15 min.
268
Hypocapnia has been associated with cerebral vasoconstriction, which in turn can lead to cerebral 269 hypoxia (Funderburk et al., 1968) . However, the calves in the current study did not present any and treated with doxapram immediately after birth had a decrease in P v CO 2 (Szenci, 1986 ) that 275 was lower than in untreated controls (Herfen, 1997). In both of these studies, hypocapnia did not 276 occur, but the P v CO 2 remained above 45 mmHg in the hypercapnic range. However, these studies 277 used venous blood, where the P v CO 2 is determined primarily by the bicarbonate in the periphery. (Szenci, 1986) . In contrast, prethcamide induced significant increases in P a O 2
285
and decreases in P a CO 2 changes in arterial blood that indicated improvement in ventilation in the 286 current study, possibly due to larger tidal volumes (V in and V exp ), as has been reported in humans 287 (Sams et al., 1997) . However, prethcamide had no effect on minute volume and we were unable 288 to explain the relationship between the increasing tidal volumes immediately after prethcamide 289 administration and the changes in P a CO 2 seen 30 min and in P a O 2 90 min post treatment.
291
Pharmacokinetic studies have shown that the maximum concentration of prethcamide in 292 blood is reached 3 min after oral administration and has decreased by 66% by 60 min
293
(Anonymous, 1998). In the current study, the stimulatory effect of oral prethcamide on 294 respiration was generally minimal and improvements in blood gas variables were greatly delayed, 295 so this drug may not be useful to treat acute asphyxia. However, it is possible that the positive 296 effect of prethcamide is more pronounced in animals with a very high P a CO 2 , although the effect 297 of prethcamide is believed to be independent of P a CO 2 , except for specific limits (Anderton and 298 Harris, 1963). showed a decrease in venous pH, BE and HCO 3 -10 min after birth (Szenci, 1986 
